Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication

Anti-Cancer Agents in Medicinal Chemistry, 15(9): 1127-1133.

Author(s): Yanan Jiang and Lijun Jia.

Affiliation: Cancer Institute, Fudan University Shanghai Cancer Center, 270 DongAn Road, Shanghai, 200032, China.


Protein neddylation, a newly characterized posttranslational modification that adds the ubiquitin-like molecule NEDD8 to substrates, modulates important biological processes, whereas dysfunction of neddylation may cause several serious diseases, such as cancer. Inhibition of neddylation pathway has emerged as a promising anticancer strategy, as evidenced by development of the NEDD8-activating enzyme (NAE) inhibitor MLN4924. Due to its potent anti-cancer efficacy and well-tolerated toxicity, MLN4924 has been evaluated in multiple Phase I clinical trials for solid tumors and hematologic malignancies. Recently, accumulating evidences indicate that neddylation pathway also plays a pivotal role in the regulation of multiple processes of tumor microenvironment (TME), such as tumor angiogenesis and the function of immune cells. In this review, we briefly summarize the latest progresses in this field and highlight neddylation pathway as an attractive therapeutic target against human cancer.


Angiogenesis, apoptosis, autophagy, neddylation, Cullin-Ring ligase, MLN4924, NEDD8-activating enzyme, senesence.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 15
Issue Number: 9
First Page: 1127
Last Page: 1133
Page Count: 7
DOI: 10.2174/1871520615666150305111257
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science